glp-1 for menopause weight gain The GLP-1/GIP dual-receptor agonist tirzepatide led to at least 15% loss of total body fat in premenopausal, perimenopausal, and postmenopausal women, but postmenopausal women taking menopausal hormone therapy had the greatest A New Study Says That

Zepbound is FDA-approved for chronic weight management and may offer enhanced results for patients struggling with obesity or weight-related health concerns

The sensitivity of the test may be affected during the day by variability in urine composition

The GLP-1 companion tools available can help track your dosing consistency over time

Meanwhile, a study published on April 17, 2026, suggested that taking a drug like semaglutide (the main ingredient in Ozempic) may be associated with an increased risk of some patients experiencing hair loss

These medications are highly effective in lowering blood sugar levels, making them a valuable option for diabetes management